Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.9%.
The iShares Biotechnology ETF (IBB) fell 1.3%.
In corporate news, Eli Lilly (LLY) has filed lawsuits against medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its weight-loss drug Zepbound, Reuters reported. Eli Lilly shares declined 0.9%.
Cigna (CI) is continuing merger talks with Humana (HUM) after such discussions fell apart last year, Bloomberg reported Friday. Cigna shares fell 4.4% while Humana was down 1.9%.
LENZ Therapeutics (LENZ) said the US Food and Drug Administration has accepted its new drug application for its LNZ100 eye drops to treat presbyopia. Its shares rose over 3%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。